- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07202767
- Original Trial
Intraocular Lens Calculation Using Artificial Intelligence
The aim of this study is to investigate the lens diameter (LD) as a useful parameter in intraocular lens (IOL) power calculation by using several different non-invasive imaging techniques. The aim is to establish an accurate model for lens diameter estimation and subsequently evaluate the influence of the LD on the effective postoperative lens position. The comparability of the different devices in terms of variability between the biometric measurements will also be assessed.
By then combining these two approaches with artificial intelligence, the aim is to develop a new approach to effectively incorporate the LD in IOL power calculation and improve patient's outcome in the long run.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
During uncomplicated cataract operation, the clouded natural lens is being removed and replaced with an artificial intraocular lens (IOL). To achieve optimal postoperative outcomes for patients, the power of the implanted artificial lens is calculated prior to surgery.
Significant progress has been made in calculation concepts over the past 20 years, including the introduction of regression, vergence and ray tracing. More recently, approaches incorporating artificial intelligence have emerged.
All these formulae are based on the biometric data of the eye. This includes parameters such as axial eye length, corneal curvature, central corneal thickness, anterior chamber depth and the refractive indices of the eye's optical segments. By including all these variables, modern formulas aim to deliver the best possible postoperative outcomes.
One variable that has not been included in the calculation thus far is the diameter of the natural lens. Large parts of the lens are covered by the iris. Even with medically dilated pupils the peripheral parts cannot be visualized, and subsequently not adequately reproduced using established imaging methods. This has made implementation in IOL power calculation difficult.
In everyday clinical practice, however, anterior segment OCT imaging devices are equipped with features that allow for an estimation of lens diameter. This is achieved by extrapolating the anterior and posterior curvature of the natural lens, which unfortunately makes this approach prone to error. Other imaging techniques, such as magnetic resonance imaging, are impractical in routine clinical practice due to time and cost considerations. However, they could be highly beneficial for future predictive approaches of the lens diameter The aim of this study is to develop a model for incorporating the lens diameter into IOL calculation. This will be achieved by using different imaging technologies to determine the actual lens diameter. The diameter will then be predicted using available biometric variables.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Nino Hirnschall, MD PhD
- Phone Number: 1056 0043(0)5768083
- Email: nino.hirnschall@kepleruniklinikum.at
Study Contact Backup
- Name: Leon Pomberger, MD
- Phone Number: 1056 0043(0)5768083
- Email: leon.pomberger@kepleruniklinikum.at
Study Locations
-
-
-
Linz, Austria, 4020
- Kepler University Clinic, Linz
-
Contact:
- Nino Hirnschall, MD, PhD
- Phone Number: 1056 0043(0)5768083
- Email: nino.hirnschall@kepleruniklinikum.at
-
Contact:
- Leon Pomberger, MD
- Phone Number: 1056 0043(0)5768083
- Email: nino.hirnschall@kepleruniklinikum.at
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion criteria
- age 21 years and older
- planned uncomplicated bilateral cataract surgery
- availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits
- ability to consent to the participation in the study
- signed informed consent
Exclusion criteria
- multifocal IOL
- combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery)
- PEX, previous ocular surgery, severe trauma or any pathology that could lead to an unstable capsular bag
- glaucoma or any other retinal disease that may affect visual acuity significantly
- pregnancy
- pre-operative visual acuity below 0.1 Snellen decimal (1.0 Log MAR)
- pupil diameter <4mm
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study Cohort with MRI
Patients who are included in this study who additionally receive a cerebral MRI
|
Device: Swept-Source Anterior Segment OCT The CASIA-2 (Tomey, Japan) is a high-resolution swept-source anterior segment OCT with CE certification. The device allows for incomplete visualization of the lens, including the anterior and posterior lens curvature. Device: AS-OCT + Placido disc corneal topography The MS-39 (CSO, Italy) is a non-invasive device that combines Placido topography with OCT-based anterior segment tomography. Device: Wave-front abberomtery The OSIRIS aberrometer is a standard tool for examining corneal aberration and measuring the ocular wavefront. Device: Swept-Source OCT The IOLMaster 700 (Carl Zeiss Meditec, Germany) is a standard swept-source OCT used for eye examinations. Device: AS-OCT The ANTERION (Heidelberg Engineering, Germany) is an anterior segment swept-source OCT. Diagnostic Test: Refraction Subjective Refraction evaluation using the cross-cylinder method |
|
Study cohort without MRI
Study cohort who doesn't receive an MRI
|
Device: Swept-Source Anterior Segment OCT The CASIA-2 (Tomey, Japan) is a high-resolution swept-source anterior segment OCT with CE certification. The device allows for incomplete visualization of the lens, including the anterior and posterior lens curvature. Device: AS-OCT + Placido disc corneal topography The MS-39 (CSO, Italy) is a non-invasive device that combines Placido topography with OCT-based anterior segment tomography. Device: Wave-front abberomtery The OSIRIS aberrometer is a standard tool for examining corneal aberration and measuring the ocular wavefront. Device: Swept-Source OCT The IOLMaster 700 (Carl Zeiss Meditec, Germany) is a standard swept-source OCT used for eye examinations. Device: AS-OCT The ANTERION (Heidelberg Engineering, Germany) is an anterior segment swept-source OCT. Diagnostic Test: Refraction Subjective Refraction evaluation using the cross-cylinder method |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prediction model to estimate lens diameter with different measurement tools (swept-AS segment OCT; anterior segment-OCT and Placido topography with OCT-based anterior segment tomography; wave-front abberometry; swept-source OCT and optical biometer)
Time Frame: preoperatively, 4 and 12 weeks post cataract surgery
|
Developing a prediction model to accurately estimate the lens diameter using biometric parameters (swept-source anterior segment Optical Coherence Topography (Casia-2), Placido topography combined with Optical Coherenece Topography-based anterior segment tomography (MS-39), wave-front abberometry (OSIRIS), Swept-Source Optical Coherence Tomography (IOLMaster 700) and anterior segment swept-source OCT (Anterion).
|
preoperatively, 4 and 12 weeks post cataract surgery
|
|
Prediction model to estimate lens diameter with cerebral Magnetic Resonance Imaging
Time Frame: 12 weeks post cataract surgery
|
Developing a prediction model to accurately estimate the lens diameter using cerebral Magnetic Resonance Imaging to examine ocular configuration
|
12 weeks post cataract surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IOL calculation concept an artificial intelligence approach
Time Frame: preoperatively, 4 and 12 weeks post cataract surgery
|
Development of a new IOL calculation concept which includes the lens diameter using an artificial intelligence approach
|
preoperatively, 4 and 12 weeks post cataract surgery
|
|
Different measurement modalities for the biometry of the eye
Time Frame: 4 and 12 weeks post cataract surgery
|
Comparison of different measurement modalities (swept-source anterior segment Optical Coherence Topography; anterior segment-Optical Coherence Tomography and Placido topography with Optical Coherenece Topography-based anterior segment tomography; wave-front abberometry; swept-source Optical Coherence Tomography and optical biometer) for the biometry of the eye
|
4 and 12 weeks post cataract surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Nino Hirnschall, MD PhD, JKU Linz
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KUK-Ophthalmology-015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.